2024 Q2 Form 10-Q Financial Statement
#000143774924017038 Filed on May 15, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $123.1K | $202.5K |
YoY Change | 5.11% | 32.83% |
Cost Of Revenue | $21.35K | $14.19K |
YoY Change | -20.84% | 23.93% |
Gross Profit | $109.7K | $190.6K |
YoY Change | 21.71% | 35.23% |
Gross Profit Margin | 89.13% | 94.16% |
Selling, General & Admin | $2.243M | $2.450M |
YoY Change | 44.92% | 40.38% |
% of Gross Profit | 2044.67% | 1285.15% |
Research & Development | $3.492M | $2.845M |
YoY Change | 10.14% | -16.26% |
% of Gross Profit | 3182.38% | 1492.7% |
Depreciation & Amortization | $2.170K | $2.177K |
YoY Change | -54.98% | -54.82% |
% of Gross Profit | 1.98% | 1.14% |
Operating Expenses | $3.492M | $2.845M |
YoY Change | 10.14% | -16.26% |
Operating Profit | -$5.636M | -$5.121M |
YoY Change | 21.64% | 2.28% |
Interest Expense | -$195.9K | $237.6K |
YoY Change | 5480.63% | 475040.0% |
% of Operating Profit | ||
Other Income/Expense, Net | -$345.6K | $778.0K |
YoY Change | 9736.69% | 1655217.02% |
Pretax Income | -$5.981M | -$4.343M |
YoY Change | 29.0% | -13.26% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$5.981M | -$4.343M |
YoY Change | 29.0% | -13.26% |
Net Earnings / Revenue | -4858.7% | -2145.25% |
Basic Earnings Per Share | -$0.21 | -$0.15 |
Diluted Earnings Per Share | -$0.21 | -$0.15 |
COMMON SHARES | ||
Basic Shares Outstanding | 28.62M | 28.72M |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $1.122M | $2.995M |
YoY Change | 33.31% | 227.28% |
Cash & Equivalents | $1.122M | $2.995M |
Short-Term Investments | ||
Other Short-Term Assets | $3.004M | $3.261M |
YoY Change | -11.17% | 20.66% |
Inventory | $241.0K | $242.5K |
Prepaid Expenses | ||
Receivables | $83.74K | $71.32K |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $4.450M | $6.570M |
YoY Change | -2.14% | 64.52% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $22.17K | $24.34K |
YoY Change | -51.34% | -51.67% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $267.7K | $593.8K |
YoY Change | 182.71% | 472.29% |
TOTAL ASSETS | ||
Total Short-Term Assets | $4.450M | $6.570M |
Total Long-Term Assets | $267.7K | $593.8K |
Total Assets | $4.718M | $7.164M |
YoY Change | 1.63% | 74.85% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $3.860M | $3.671M |
YoY Change | -36.5% | -18.11% |
Accrued Expenses | $1.577M | $1.746M |
YoY Change | 8927.36% | 10187.8% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $2.711M | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $9.829M | $6.536M |
YoY Change | 61.24% | 45.27% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $12.38K | $17.51K |
YoY Change | -61.24% | -52.07% |
Total Long-Term Liabilities | $12.38K | $17.51K |
YoY Change | -61.25% | -52.07% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $9.829M | $6.536M |
Total Long-Term Liabilities | $12.38K | $17.51K |
Total Liabilities | $9.841M | $6.554M |
YoY Change | 60.6% | 44.48% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$94.18M | -$88.20M |
YoY Change | 28.24% | 28.19% |
Common Stock | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$5.123M | $610.0K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $4.718M | $7.164M |
YoY Change | 1.63% | 74.85% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$5.981M | -$4.343M |
YoY Change | 29.0% | -13.26% |
Depreciation, Depletion And Amortization | $2.170K | $2.177K |
YoY Change | -54.98% | -54.82% |
Cash From Operating Activities | -$3.848M | -$6.182M |
YoY Change | 10.62% | 41.46% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 1.975M | -$69.28K |
YoY Change | -42.0% | -101.85% |
NET CHANGE | ||
Cash From Operating Activities | -3.848M | -$6.182M |
Cash From Investing Activities | ||
Cash From Financing Activities | 1.975M | -$69.28K |
Net Change In Cash | -1.873M | -$6.251M |
YoY Change | 2443.61% | 895.06% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$3.848M | -$6.182M |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9246592 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
17507 | usd |
CY2024Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
17507 | usd |
CY2024Q1 | us-gaap |
Salaries And Wages
SalariesAndWages
|
822481 | usd |
CY2023Q1 | us-gaap |
Salaries And Wages
SalariesAndWages
|
906955 | usd |
CY2024Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2995000 | usd |
CY2024Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2024Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2024Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000922247 | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | pure |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
0 | usd |
CY2024Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
0 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | usd |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2995000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6182000 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-88200000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4343000 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
10272 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
13247538 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1010631 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
5888813 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6536369 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | usd |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
28614384 | |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
28614384 | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
28556072 | |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
28556072 | |
CY2024Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
2862 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
2856 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
88806896 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
88610832 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-88199744 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-83856681 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
610014 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4757007 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7163890 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
13247538 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
202450 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
152411 | usd |
CY2024Q1 | ctdh |
Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
|
11823 | usd |
CY2023Q1 | ctdh |
Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
|
10196 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
190627 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
142215 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2845483 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3398167 | usd |
CY2024Q1 | ctdh |
Repairs And Maintenance
RepairsAndMaintenance
|
2363 | usd |
CY2023Q1 | ctdh |
Repairs And Maintenance
RepairsAndMaintenance
|
1252 | usd |
CY2024Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
630388 | usd |
CY2023Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
482835 | usd |
CY2024Q1 | us-gaap |
Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
|
892213 | usd |
CY2023Q1 | us-gaap |
Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
|
282375 | usd |
CY2024Q1 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
104398 | usd |
CY2023Q1 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
72125 | usd |
CY2024Q1 | us-gaap |
Depreciation Nonproduction
DepreciationNonproduction
|
2177 | usd |
CY2023Q1 | us-gaap |
Depreciation Nonproduction
DepreciationNonproduction
|
4819 | usd |
CY2024Q1 | ctdh |
Freight And Shipping
FreightAndShipping
|
373 | usd |
CY2023Q1 | ctdh |
Freight And Shipping
FreightAndShipping
|
819 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-11813 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-0 | usd |
CY2024Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
5311689 | usd |
CY2023Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
5149347 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5121062 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5007132 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
237568 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
47 | usd |
CY2024Q1 | us-gaap |
Lease Income
LeaseIncome
|
540431 | usd |
CY2023Q1 | us-gaap |
Lease Income
LeaseIncome
|
0 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
777999 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
47 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-4343063 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5007085 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4343063 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5007085 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.15 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.46 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
28585228 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
11003588 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4757007 | usd |
CY2024Q1 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
69281 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
173218 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4343063 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
610014 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
734544 | usd |
CY2023Q1 | ctdh |
Stock Issued During Period Value Common Stock And Prefunded Warrants
StockIssuedDuringPeriodValueCommonStockAndPrefundedWarrants
|
3741883 | usd |
CY2023Q1 | ctdh |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
114 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
91668 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5007085 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-438876 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4343063 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5007085 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2177 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4819 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-11813 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-0 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
173218 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
91668 | usd |
CY2024Q1 | ctdh |
Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
|
92133 | usd |
CY2023Q1 | ctdh |
Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
|
0 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-51057 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
76233 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-11822 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-9994 | usd |
CY2024Q1 | ctdh |
Increase Decrease Prepaid Clinical Expenses
IncreaseDecreasePrepaidClinicalExpenses
|
508159 | usd |
CY2023Q1 | ctdh |
Increase Decrease Prepaid Clinical Expenses
IncreaseDecreasePrepaidClinicalExpenses
|
309403 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
|
104528 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
|
87503 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-0 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-1573 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1568603 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1001931 | usd |
CY2024Q1 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
-1839070 | usd |
CY2023Q1 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
636846 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6182133 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4370239 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
2407849 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1334034 | usd |
CY2024Q1 | us-gaap |
Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
|
69281 | usd |
CY2023Q1 | us-gaap |
Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
|
-0 | usd |
CY2024Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | usd |
CY2023Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
114 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-69281 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3741997 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6251414 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-628242 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
9246592 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1543418 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2995178 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
915176 | usd |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
756 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1730 | usd |
CY2024Q1 | ctdh |
Working Capital Deficit
WorkingCapitalDeficit
|
34000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
10000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
202450 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
152411 | usd |
CY2024Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3670646 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4856530 | usd |
CY2024Q1 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
996161 | usd |
CY2023Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
1590776 | usd |
CY2024Q1 | ctdh |
Accrued Board Expense Current
AccruedBoardExpenseCurrent
|
102125 | usd |
CY2023Q4 | ctdh |
Accrued Board Expense Current
AccruedBoardExpenseCurrent
|
92110 | usd |
CY2024Q1 | us-gaap |
Deposit Liability Current
DepositLiabilityCurrent
|
243742 | usd |
CY2023Q4 | us-gaap |
Deposit Liability Current
DepositLiabilityCurrent
|
243742 | usd |
CY2024Q1 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
487342 | usd |
CY2023Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
487402 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
388797 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
186856 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
5888813 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
7457416 | usd |
CY2024Q1 | ctdh |
Operating Lease Right Of Usse Asset Amortization
OperatingLeaseRightOfUsseAssetAmortization
|
321472 | usd |
CY2023Q4 | ctdh |
Operating Lease Right Of Usse Asset Amortization
OperatingLeaseRightOfUsseAssetAmortization
|
17242 | usd |
CY2024Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
527417 | usd |
CY2023Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
9535 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4343063 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5007085 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
28585228 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
11003588 | |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.15 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.46 | |
CY2024Q1 | us-gaap |
Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
|
980000 | usd |